Topical corticosteroid-induced rosacea-like dermatitis: A clinical study of 110 cases

Rathi, Sahaj; Kumrah, Leishiwon

doi:10.4103/0378-6323.74974

Cited by 59 publications

(61 citation statements)

References 17 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[15][16][17][18][19][20][21][22][23] Case reports of patients suffering from various effects of misuse of TCS have regularly been discussed in ACAD_IADVL. Emphasizing the pandemic use of these combination drugs required the same force and awareness campaign for the controlling of their misuses.…”

mentioning

confidence: 99%

Topical steroid abuse on face: a prospective study from a tertiary care centre of north India

et al. 2017

View full text Add to dashboard Cite

Background: Topical corticosteroids (TCS) are widely misused on face which is associated with significant adverse effects and poor awareness of these effects. The aim of this study was to assess the frequency of misuse of topical corticosteroids, the causes behind it and the most common adverse events resulting from it and to make aware the people about itMethods: This study was conducted at Dermatology Department of Govt. Medical College, Kota during period of one year from July 2015 to June 2016. A total of 670 patients using topical steroids over face were enrolled in the study. Details about the usage of topical corticosteroids and their side effects were recorded.Results: Majority of the patients were females (72.68%). The most common reason for misuse was melasma (57. 91%) followed by use as a fairness cream (22.38%). Most of the patient used topical steroid cream for duration of 3-6 months (33.13%). Most common age group was 21-30 years (48.20%). Acne form eruption (38.05%) and rebound erythema (28.20%) were the most common adverse effects noted. Patients were ignorant of the ingredients and their side effects.Conclusions: Steroids have been misused by patients on their own or by pharmacist and non-dermatologist physicians for various reasons. Topical steroid should not be used on the face unless it is under strict dermatological supervision.

show abstract

mentioning

confidence: 99%

Topical steroid abuse on face: a prospective study from a tertiary care centre of north India

et al. 2017

View full text Add to dashboard Cite

show abstract

“…In this study we have observed that use of dexamethasone-cyclophosphamide pulse therapy for 18 25,26 Prescriptions with polypharmacy were 9.9%. It is evident that there is good deal of tendency towards polypharmacy in dermatology for the symptomatic treatment for severe and troublesome symptoms.…”

Section: Discussionmentioning

confidence: 89%

“…It is similar to the study conducted by Rathi SK et al which showed betamethasone 58.8% as the commonest topical corticosteroid prescribed. 18 While other studies by Divyashanti CM et al, Uppal R et al and Sarvanakumar RT et al showed clobetasol and other very high potent topical corticosteroids were common prescribed. 19,20 In our study clobetasol was the second most prescribed drug.…”

Section: Discussionmentioning

confidence: 96%

Corticosteroids used in dermatology: its utilisation and cost analysis study

Lamani¹,

Bhushan²

2016

Int J Basic Clin Pharmacol

View full text Add to dashboard Cite

“…Interestingly, eye problems are reportedly absent. 29 Treatment involves a fine balance between gradual tapering to complete cessation of the topical steroid and addition of oral anti-inflammatory antibiotics and/or topical antibiotics.…”

Section: Secondary Telangiectasia With Skin Atrophymentioning

confidence: 99%

A clinical approach to diagnose patients with localized telangiectasia

et al. 2015

View full text Add to dashboard Cite

Telangiectasia, or dilated blood vessels, may represent a benign condition or a marker of a much more serious internal or cutaneous malignancy (e.g. mycosis fungoides). They can be generalized or localized in distribution. ‘Localized telangiectasia? can be macular or papular. Macular ones can be further divided into two major categories: primary and secondary. They can occur on their own (primary), after skin injury (e.g. sun damage, post‐radiation therapy, after prolonged topical steroid application), or may arise due to an underlying condition (secondary). While telangiectases can spring from a multitude of possible causes, the location of the lesions, in combination with a careful history and exmination, often helps in elucidating the correct diagnosis. A patient with localized telangiectasia as a manifestation of malignancy may be difficult to diagnose, however the diagnosis is one of exclusion, and a thorough evaluation should be performed before diagnosing this condition. This article reviews possible conditions to consider in these patients and suggests an approach to their evaluation.

show abstract

Topical corticosteroid-induced rosacea-like dermatitis: A clinical study of 110 cases

Abstract: Varied clinical presentations are seen with prolonged and continuous use of topical steroids. The treatment of this dermatitis is difficult, requiring complete cessation of the offending steroid, usually done in a tapering fashion.

Cited by 59 publications

References 17 publications

Topical steroid abuse on face: a prospective study from a tertiary care centre of north India

Topical steroid abuse on face: a prospective study from a tertiary care centre of north India

Corticosteroids used in dermatology: its utilisation and cost analysis study

A clinical approach to diagnose patients with localized telangiectasia

Contact Info

Product

Resources

About